Metallic nanoparticles and their medicinal potential. Part II: Aluminosilicates, nanobiomagnets, quantum dots and cochleates

Therapeutic Delivery

Volumn 4, Issue 9, 2013, Pages 1179-1196

  Loomba, Leena ^a   Scarabelli, Tiziano ^b  

^a PUNJAB AGRICULTURAL UNIVERSITY   (India)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINOSILICATE NANOPARTICLE; ALUMINUM; ALUMINUM SILICATE; AMPHOTERICIN B; ANTIINFECTIVE AGENT; BENTONITE; CADMIUM; CALCIUM; CLOFAZIMINE; CONTRAST MEDIUM; FERRISTENE; FERUMOXSIL; GOLD NANOPARTICLE; INDIUM; IRON; IRON OXIDE; MAGNESIUM; METAL NANOPARTICLE; NANOMATERIAL; NAPROXEN; QUANTUM DOT; SELENIUM; SILICATE; SILICON; SILICON DIOXIDE; SILVER NANOPARTICLE; TELLURIUM; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC;

ANTIMICROBIAL ACTIVITY; BIOMAGNETISM; BIOMEDICAL ENGINEERING; BIOSENSOR; CANCER THERAPY; CELL ASSAY; COCHLEATE; DIAGNOSTIC IMAGING; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; ELECTROCHEMICAL ANALYSIS; ELECTRONICS; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENCE SPECTROSCOPY; GENE TARGETING; GENE THERAPY; GENETIC PROCEDURES; HUMAN; HYPERTHERMIA; LABELING INDEX; NANOMEDICINE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SEMICONDUCTOR; SYNTHESIS; TOXICOLOGY; WOUND HEALING;

EID: 84884143291     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.13.74     Document Type: Review

References (85)

1. Zhai SR, He CS, Wu D, Sun YH. Hydrothermal synthesis of mesostructured aluminosilicate nanoparticles assisted by binary surfactants and finely controlled assembly process. J. Non-Crystalline Solids 353, 1606-1611 (2007).
2. Nampi PP, Moothetty P, Berry FJ, Mortimer M, Warrier KG. Aluminosilicates with varying alumina-silica ratios: synthesis via a hybrid sol gel and structural characterization. Daltons Trans. 39, 5101-5107 (2010).
3. Kannewischer I, Arvide MGT, White GN and Dixon JB. Smectite clays as adsorbents of aflatoxin B1: initial steps. Clay Science 12 (2), 199-204 (2006).
4. Williams LB, Metge DW, Dennis D, Eberl DD. What makes a natural clay antibacterial? Environ. Sci. Technol. 45(8), 3768-3773 (2011).
5. Haydel SE, Remenih CM, Williams LB. Broad-spectrum in vitro antibacterial activities of clay minerals against antibiotic-susceptible and antibiotic-resistant bacterial pathogens. J. Antimicrob. Chemother. 61(2), 353-361(2008).
6. Oh JM, Biswicka TT, Choy JH. Layered nanomaterials for green materials. J. Mater. Chem. 19, 2553-2563 (2009).
7. Laurent S, Bridot JL, Elst LV, Muller RN. Magnetic iron oxide nanoparticles for biomedical applications. Future Med. Chem. 2(3), 427-449 (2010).
8. Eastoe J, Hollamby MJ, Hudson L. Recent advances in nanoparticle synthesis with reversed micelles. Adv. Coll. Interf. Sci. 128-130, 5-15 (2006).
9. Wright B N, Rangari V, Jeelani S. Synthesis of magnetic nanoparticles and its applications in drug delivery systems. Nanotech. 2, 390-393 (2008).
10. Nitin N, LaConte LE, Zurkiya O et al. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J. Biol. Inorg. Chem. 9, 706-712 (2004).
11. Islam T, Josephson L. Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles. Cancer Biomark. 5(2), 99-107 (2009).
12. Corot C, Robert P, Idee JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug. Deliv. Rev. 58(14), 1471-1504 (2006).
13. Tanimoto A, Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur. J. Radiol. 58(2), 200-216 (2006).
14. Sreeram KJ, Nidhin M, Unni Nair B. Synthesis of aligned hematite nanoparticles on chitosan-alginate films. Colloids Surfaces B: Biointerfaces. 71 (2), 260-267 (2009).
15. Lee N, Hyeon T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem. Soc. Rev. 41(7), 2575-2589 (2012).
16. Peng XH, Qian X, Mao H. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int. J. Nanomed. 3(3), 311-321 (2008).
17. Yang L, Peng XH, Wang YA et al. Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin. Cancer Res. 15(14), 4722-4732 (2009).
18. Kluchova K, Zboril R, Tucek J et al. Superparamagnetic maghemite nanoparticles from solid-state synthesis - their functionalization towards peroral MRI contrast agent and magnetic carrier for trypsin immobilization. Biomaterials 30, 2855-2863 (2009).
19. Skaat H, Margel S. Synthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-beta fibrils detection and removal by a magnetic field. Biochem. Biophys. Res. Commun. 386(4), 645-649 (2009).
20. Mornet S, Grasset F, Portier J, Duguet E. Maghemite@silica nanoparticles for biological applications. Eur.Cells Mat. 3 (2), 110-113 (2002).
21. Mahler B, Spinicelli P, Buil S, Quelin X, Hermier JP, Dubertret B. Towards non-blinking colloidal quantum dots. Nat. Mater. 7, 659-664 (2008).
22. Yokota H, Tsunashima K, Iizuka K, Okamoto H. Direct electron beam patterning and molecular beam epitaxy growth of InAs: site definition of quantum dots. J. Vac. Sci. Technol. B. 26, 1097-1099 (2008).
23. Lee SW, Mao C, Flynn CE, Belcher AM. Ordering of quantum dots using genetically engineered viruses. Science 296 (5569), 892 (2002).
24. Pinaud F, Michalet X, Iyer G, Margeat E, Moore HP. Weiss S. Dynamic partitioning of a glycosyl-phosphatidylinositol-anchored protein in glycosphingolipid-rich microdomains imaged by single-quantum dot tracking. Traffic 10, 691-712 (2009).
25. Patha S, Choi SK, Arnheim N, Thompson ME. Hydroxylated quantum dots as luminescent probes for in situ hybridization. J. Am. Chem Soc. 123, 4103-4104 (2001).
26. Wu X, Liu H, Liu J et al. Immunofluorescent labeling of cancer marker HER2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol. 21, 41-46 (2003).
27. Michalet X, Pinaud FF, Bentolila LA et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307(5709), 538-544 (2005).
28. Lugo K, Miao X, Rieke F, Lin LY. Remote switching of cellular activity and cell signaling using light in conjunction with quantum dots. Biomedi. Opt. Exp. 3(3), 447-454 (2012).
29. Walling MA, Shepard N. Quantum dots for live cell and in vivo imaging. Int. J. Mol. Sci. 10(2), 441-449 (2009).
30. Lifeng Q, Xiaohu G. Emerging application of quantum dots for drug delivery and therapy. Expert Opin. Drug Deliv. 5(3), 263-267 (2008).
31. Mathuria JP. Nanoparticles in tuberculosis diagnosis, treatment and prevention: a hope for the future. Digest J. Nanomaterials Biostructures 4, 309-312 (2009).
32. Tokumasu F, Fairhurst RM, Ostera GR et al. Band 3 modifications in Plasmodium falciparum-infected AA and CC erythrocytes assayed by autocorrelation analysis using quantum dots. J. Cell Sci. 118, 1091-1098 (2005).
33. Dyadyusha L, Yin H, Jaiswal S et al. Quenching of CdSe quantum dot emission, a new approach for biosensing. Chem. Commun. 3201-3203 (2005).
34. Kattke MD, Gao EJ, Sapsford KE, Stephenson LD, Kumar A. FRET-based quantum dot immunoassay for rapid and sensitive detection of Aspergillus amstelodami. Sensors 11, 6396-6410 (2011).
35. Algar WR, Susumu K, Delehanty JB, Medintz IL. Semiconductor quantum dots in bioanalysis: crossing the valley of death. Anal. Chem. 83, 8826-8837 (2011).
36. Yildiz I, Gao X, Harris TK, Raymo FM. Fluorescence resonance energy transfer in quantum kinase assemblies. Biomed.Biotechnol. 2007, 18081(2007).
37. Zarif L, Graybill J, Perlin D, Mannino RJ. Cochleates: new lipid based drug delivery system. J. Lip. Res. 10, 523-538 (2000).
38. Mannino R, Gold-Foserite S, Kheiri MT, Zhang F, Wang Z. Targeting immune response induction with cochleate and liposomes based vaccines. Adv. Drug Deliv. 32, 237-287 (1998).
39. Syeda UM, Wooa AF, Plakogiannisa F, Jina T, Zhu H. Cochleates bridged by drug molecules. Int. J. Pharm. 363(1-2), 118-125 (2008).
40. Zarif L, Mannino RJ. Cochleates: new lipid based vehicles for gene deliveries, cancer gene therapy. Adv. Exp. Med. Biol. 465, 83-94, (2000).
41. Campo S, Arseni B, Rossi S et al. Efficacy of a nanocochleate- encapsulated 3,5-diaryl-s-triazole derivative in a murine model of graft-versus-host disease. Transplantation 86(1), 171-175 (2008).
42. Jin T, Pennefather P, Lee PI. Lipobeads: a hydrogel anchored lipid vesicle system. FEBS Letters 97, 70-74 (1996).
43. Gibson B, Duffy AM et al. A novel gene delivery system for mammalian cells. Anticancer Res. 24, 483-488 (2004).
44. Parker G, Peng B, He M, Gould-Fogerite S, Chou C, Raveche ES. In vivo and in vitro anti-proliferative effects of antisense IL-10 oligonucleotides in antisense technology: part B. In: Methods in Enzymology. Phillips MI (Ed.). Academic Press, NY, USA, 411-429 (1999).
45. Gao N, Keane MJ, Ong T, Wallace WE. Effects of simulated pulmonary surfactant on the cytotoxicity and DNA-damaging activity of respirable quartz and kaolin. J. Toxicol. Environ. Health A. 60(3), 153-167 (2000).
46. Gao N, Keane MJ, Ong T et al. Respirable quartz and kaolin alumino-silicate induction of in vitro cytotoxicity and apoptosis in the presence of surfactant or serum: caveats to bioassay interpretation. Ann. Occup. Hyg. 46(1), 50-52 (2002).
47. Petushkov A, Ndiege N, Salem AK, Larsen SC. Chapter 7 - toxicity of silica nanomaterials: zeolites, mesoporous silica, and amorphous silica nanoparticles. Adv. Mol. Toxicol. 4, 223-266 (2010).
48. Kihara T, Zhang Y, Hu Y, Mao Q, Tang Y, Miyake J. Effect of composition, morphology and size of nanozeolite on its in vitro cytotoxicity. J. Biosci. Bioengin. 111(6), 725-730 (2011).
49. Das S, Debnath N, Patra P, Datta A, Goswami A. Nanoparticles influence on expression of cell cycle related genes in Drosophila: a microarray-based toxicogenomics study. Toxicol. Environ. Chem. 94(12), 952-957 (2012).
50. Abdel-Wahhab MA, Nada SA, Amra HA. Effect of aluminosilicates and bentonite on aflatoxin-induced developmental toxicity in rat. J Appl Toxicol. 19(3), 199-204 (1999).
51. Li PR, Wei JC, Chiu YF, Su HL, Peng FC, Lin JJ. Evaluation on cytotoxicity and genotoxicity of the exfoliated silicate nanoclay. ACS Appl. Mater. Interfaces 2(6), 1608-1613 (2010).
52. Das S, Bhattacharya A, Debnath N, Datta A, Goswami A. Nanoparticle-induced morphological transition of Bombyx mori nucleopolyhedrovirus: a novel method to treat silkworm grasserie disease. App. Microbiol. Biotechnol. 97(13), 6019-6030 (2013).
53. Thomassen LC, Napierska D, Dinsdale D et al. Investigation of the cytotoxicity of nanozeolites A and Y. Nanotoxicology 6(5), 472-485 (2012).
54. Han HK, Lee YC, Lee MY, Patil AJ, Shin HJ. Magnesium and calcium organophyllosilicates: synthesis and in vitro cytotoxicity study. ACS Appl. Mater. Interfaces 3 (7), 2564-2572 (2011).
55. Soenen SJ, Himmelreich U, Nuytten N, Cuyper MD. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 32(1), 195-205 (2011).
56. Soenen SJ, Nuytten N, de Meyer SF, de Smedt SC, de Cuyper M. High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinase-mediated signaling. Small 6(7), 832-842 (2010).
57. Singha N, Jenkinsa GJS, Asadib R, Doaka SH. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 1, 5358 (2010).
58. Xiang Yi, Wang J. Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant. Imaging Med. Surg. 1(1), 35-40 (2011).
59. Auffan M, Rose J, Wiesner MR, Bottero JY. Chemical stability of metallic nanoparticles: a parameter controlling their potential cellular toxicity in vitro. Environmental Pollution 157(4) 1127-1133 (2009).
60. Ankamwar B, Lai TC, Huang JH et al. Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology 21, 75102 (2010).
61. Lee N, Kim H, Choi SH et al. Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets. Proc. Natl Acad. Sci. USA 108(7), 2662-2667 (2011).
62. S-f Shi, J-f Jia, X-k Guo et al. Toxicity of iron oxide nanoparticles against osteoblasts. J. Nanopart. Res. 14, 1091 (2012).
63. Lu J, Ma S, Sun J et al. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging. Biomaterials 30, 2919-2928 (2009).
64. Derfus A. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 4, 11-18 (2004).
65. Hoshino A, Hanaki K, Suzuki K, Yamamoto K. Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body. Biochem. Biophys. Res. Commun. 314, 46-53 (2004).
66. Lovric J, Bazzi HS, Cuie Y, Fortin, GR, Winnik FM, Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J. Mol. Med. 83(5), 377-385 (2005).
67. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22, 969-976 (2004).
68. Ma J, Chen J, Guo J et al. Photostability of thiol-capped CdTe quantum dots in living cells: the effect of photo-oxidation. Nano Technol. 7, 2083-2089 (2006).
69. Silver S. Bacterial resistances to toxic metal ions - a review. Gene 179, 9-19 (1996).
70. Wang L, Zheng H, Long Y et al. Rapid determination of the toxicity of quantum dots with luminous bacteria. J. Hazard. Mat. 177, 1134-1137 (2010).
71. Mashino T, Usui N, Okuda K, Hirota P, Mochizuki M. Respiratory chain inhibition by fullerene derivatives: hydrogen peroxide production caused by fullerene derivatives and a respiratory chains system. Bioorg. Med. Chem. 11, 1433-1438 (2003).
72. Stahl CV, Almeida D, Thomas AA et al. Studying nanotoxic effects of CdTe quantum dots in Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz. 106, 158-165. (2011).
73. Yan M. An in vitro study of vascular endothelial toxicity of CdTe quantum dots. Toxicology 282(3), 94-103 (2011).
74. Chen N. The cytotoxicity of cadmium-based quantum dots. Biomaterials 33(5), 1238-1244 (2012).
75. Contreras EQ, Cho M, Zhu H et al. Toxicity of quantum dots and cadmium salt to caenorhabditis elegans after multigenerational exposure. Environ. Sci. Technol. 47 (2), 1148-1154 (2013).
76. Hauck TS, Anderson RE, Fischer HC, Newbigging S, Chan WC. In vivo quantum-dot toxicity assessment. Small 6(1), 138-144 (2010).
77. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 15(1), 79-86 (2004).
78. Infante-Bourzac JF, Sifontes-Rodríguez S, Arencibia-Arrebola DF, Hernández-Salazar T, Fariñas-Medina M, Pérez O. Toxicological assessment of the cochleate derived from neisseria meningitidis proteoliposome in Sprague Dawley rats. N. Am. J. Med. Sci. 4(3), 135-140 (2012).
79. Zarif L, Graybill JR, Perlin D, Najvar L, Bocanegra R, Mannino RJ. Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model. Antimicrob. Agents Chemother. 44(6), 1463-1469 (2000).
80. Sesana AM, Monti-Rocha R, Vinhas SA, Morais CG, Dietze R, Lemos EM. In vitro activity of amphotericin B cochleates against Leishmania chagasi. Mem. Inst. Oswaldo Cruz. 106(2), 251-253 (2011).
81. Bertrand Dupont. Overview of lipid formulations of amphotericin B. J. Antimicrob. Chemother. 49, 31-36 (2002).
82. Gibson B, Fogerite SG, Krause-Elsmore S et al. In vivo gene delivery using cochleates. Proc. Amer. Assoc. Cancer Res. 47 (2006).
83. Z-Medica. From the battlefield to the sterile field.www.z-medica.com
84. The Nanotechnology Times.http://thenanotechnologytimes.com
85. Drug Development and Delivery.www.drugdeliverytech.com